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Table. Clinical outcomes in all study patients
Medication Revascularization
Unadjusted
HR (95% CI)
p
Value
3Adjusted HR(95%
CI)
p
Value
Total population
(n¼738)
n¼236 n¼502
All-cause death 44 (18.6) 39 (7.8) 0.39 (0.26-0.61) <0.01 0.44 (0.27-0.71) <0.01
Cardiac death 23 (9.7) 17 (3.4) 0.33 (0.18-0.61) <0.01 0.29 (0.15-0.58) <0.01
MI 2 (0.8) 4 (0.8) 0.91 (0.17-4.98) 0.92 1.04 (0.16-6.80) 0.97
1Repeat
revascularization
37 (15.7) 34 (6.8) 0.38 (0.24-0.61) <0.01 0.38 (0.23-0.63) <0.01
2MACE 59 (25.0) 51 (10.2) 0.36 (0.25-0.52) <0.01 0.32 (0.21-0.49) <0.01
Data are presented as n (%).
1Repeat revascularization included target vessel revascularization-PCI, non-target vessel
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Transradial CTO PCI can be performed with similar success and
complication rates with transfemoral CTO PCI, but is associated with longer proce-
dural and ﬂuoroscopy times.
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Background: Patients with coronary artery disease with a chronic total occlusion (CTO)
are associated with worse clinical outcome compared to patients without a CTO.
Percutaneous coronary intervention (PCI) of CTOs may have a beneﬁcial effect on
survival. In literature mainly small, observational and predominantly single center studies
exist about successful PCI and the impact on reducing long-term mortality for CTO.
Methods: This meta-analysis compared the long-term mortality of successful versus
failed PCI for CTO. Relevant studies were examined and analyzed independently by
two investigators. To prevent distortion of the results by the inclusion of (sub-)acute
100% occlusions, a subgroup analysis was performed on only those studies which
included patients with a CTO of at least 3 months.
Results: We identiﬁed 27 studies eligible for inclusion in this meta-analysis, including
11,085 CTO patients with successful and 4,347 CTO patients with unsuccessful revas-
cularization (mean follow-up duration 1 to 10 years). We did not ﬁnd any randomized
controlled trials between CTO PCI versus medical treatment only. Successful CTO PCI
was associated with reduced mortality in comparison to failed CTO PCI (odds ratio
(OR): 0.52, 95%CI: 0.43-0.62,p-value¼ 0.01). For the subgroup analyses the results
remained qualitatively similar (OR: 0.47, 95%CI: 0.35-0.64, p-value < 0.01) (ﬁgure 1).
Conclusions: This meta-analysis conﬁrmed previous ﬁndings of a reduced mortality
after successful versus failed CTO PCI. Randomized controlled trials are needed to
conﬁrm the value of PCI in patients with a CTO in reducing the mortality.revascularization-PCI and coronary artery bypass grafting (CABG).
2Major adverse cardiac events (MACE) included cardiac death, MI, and repeat revasculariza-
tion with PCI or CABG.
3Adjusted covariates include age, ACS, CTO of LAD, multiple CTOs, previous PCI and Proximal
to mid CTO
ACS ¼ acute coronary syndrome; CI ¼ conﬁdence interval; CTO ¼ coronary chronic total oc-
clusion; HR ¼ hazard ratio; LAD ¼ left anterior descending artery; MI ¼ myocardial infarction;
PCI ¼ percutaneous coronary interventionTCT-197
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Therapy in Patients with Coronary Chronic Total Occlusion and Well-developed
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Background: Little is known about the clinical outcomes and optimal treatment
strategies of chronic total occlusion (CTO) with well-developed collateral circulation.B58 JACC Vol 64/11/Suppl BMethods: We screened 2,024 consecutive patients with at least one CTO detected on
coronary angiogram. Of these, we analyzed data from 738 patients with Rentrop 3
grade collateral circulation who were treated with medical therapy alone (n¼236),
coronary artery bypass grafting (n¼170) or percutaneous coronary intervention (PCI)
(n¼332; 80.1% successful). Patients who underwent revascularization and medical
therapy (revascularization group, n ¼502) were compared to those who underwent
medical therapy alone (medication group, n¼236) in terms of cardiac death and major
adverse cardiac events (MACE), deﬁned as the composite of cardiac death, myocar-
dial infarction, or repeat revascularization.
Results: During a median follow-up duration of 42 months, multivariate analysis
revealed a signiﬁcantly lower incidence of cardiac death (hazard ratio [HR] 0.29; 95%
conﬁdence interval [CI] 0.15 to 0.58; p< 0.01) and MACE (HR 0.32; 95% CI 0.21 to
0.49; p< 0.01) in the revascularization group compared to the medication group. After
propensity score matching, the incidence of cardiac death (HR 0.27; 95% CI 0.09 to
0.80; p¼0.02) and MACE (HR 0.44; 95% CI 0.23 to 0.82; p¼0.01) were still
signiﬁcantly lower in the revascularization group than in the medication group.Conclusions: In patients with coronary CTO and well-developed collateral circula-
tion, aggressive revascularization may reduce the risk of cardiac mortality and MACE.
These ﬁndings need to be conﬁrmed in randomized controlled trials.
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Background: The aim of this study was to describe the ﬁve-year European experience
of retrograde percutaneous coronary interventions (PCI) revascularization for complex
chronic total occlusions (CTOs) of coronary arteries.
Methods: Demographic data, procedural outcomes and in-hospital clinical events
were collected on 1582 consecutive lesions of 1395 patients enrolled between January
2008 and December 2012 having retrograde CTO PCI at 44 European medical centers
by 45 experienced interventionalist operators. A retrograde J-CTO score was used to
better describe success according to lesion difﬁculty. Data about clinical follow-up
were collected.
Results: Patients mean age was 62.0  10.4 years. During the procedure the retro-
grade approach was used as ﬁrst line strategy in 76.2% of cases, while immediately
after antegrade failed approach in 23.8% of cases. Procedural success was achieved
in 75.3% of cases. A major complication occurred in 16 patients (1.0%). In multi-
variable analysis, age of the patient (per 10-year increase) (OR:1.19, 95%CI:1.03-
1.34; p¼0.02), lower operator volume (OR:3.00, 95%CI:2.41-4.21; p< 0.001) and
increased retrograde J-CTO score (OR:0.42, 95%CI:0.24-0.74; p< 0.001) were
recognized as independent predictors of procedural failure. The mean follow-up
period was 24.7  15.0 months. Major adverse cardiac and cerebral events
(MACCE) occurred in 13.6% of cases (cardiac death 1.9%, myocardial infarction
3.2%, stroke 0.6% and target vessel revascularization 13%). By multivariate Cox
regression, the independent predictors of MACCE were: male gender (HR:0.47, 95%
CI:0.30-0.74; p¼0.01); prior myocardial infarction (HR:1.45, 95%CI:1.01-2.09;
p¼0.04); number of previous attempts (HR:1.63, 95%CI:1.36-1.95; p< 0.001); CTO
length (HR:1.01, 95%CI:1.00-1.02; p¼0.004); and total stent length (HR:0.98, 95%
CI:0.97-0.98;p< 0.001).
Conclusions: In Europe among selected centers dedicated to CTO revascularization,
retrograde approach was performed over a 5-year period in 16.5% of these patients.j September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMThe number of retrograde procedures were exponentially increasing during the last 2
years and were associated with high success, low major complications rates and good
outcome.
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Background: Little is known of the potential effects of successful revascularization of
chronic total occlusions (CTO) on left ventricular (LV) function. LV global longitu-
dinal strain (GLS) is a more sensitive measure of LV mechanics than LV ejection
fraction (EF). GLS can be assessed with two-dimensional speckle-tracking echocar-
diography (2DSTE) and is signiﬁcantly related to long-term clinical outcome in pa-
tients with chronic ischemic heart disease. This study was conducted to investigate the
impact of revascularization of CTO on LV function using LV GLS.
Methods: A total of 70 patients (668.9 years, 59 males, LVEF 5212%) with CTO
who underwent percutaneous coronary intervention (PCI) were included in this study.
Echocardiography was performed before the procedure and 9 month after the pro-
cedure with conventional assessment including LV end-diastolic and end-systolic
volume (LVEDV, LVESV), LVEF, and with 2DSTE analysis of GLS.
Results: Successful PCI (TIMI 3 ﬂow) was obtained in 60 patients (86%). There were
no stent thromboses during follow-up. GLS showed a signiﬁcant improvement 9
months after successful PCI (⊿¼2.12.8%; P< 0.01), whereas that in failed PCI
group did not change signiﬁcantly (⊿¼-0.94.1%; P¼0.49). ⊿GLS is greater in
successful PCI group than failed group (p¼0.005). LVEF, LVEDV and LVESV did
not change during follow-up in both successful and failed groups.Conclusions: Successful PCI for CTO improves left ventricular function assessed by
LV GLS. This improvement may be associated with the long-term beneﬁcial effect of
PCI for CTO lesions.
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Background: Chronic total occlusion (CTO) in the non-infarcted-related artery was
reported to worsen immediate clinical outcome in patients with acute myocardial
infarction (AMI). However, the prognosis of such patients with preserved left ven-
tricular function has not been clariﬁed yet. Our objectives were to evaluate whether the
presence of CTO solely contributes to worsen the prognosis in the patients with well-
preserved heart function after primary PCI.
Methods:Weretrospectively evaluated 370 consecutiveAMIpatientswith preserved left
ventricular pump function (left ventricular ejection fraction; LVEF >40%) who under-
went primary percutaneous coronary intervention (PCI) in our hospital between January
2008 and December 2012. AMI patients complicated with cardiopulmonary arrest out of
the hospital (n¼33), having the left main trunk culprit lesion (n¼23), and diagnosed after
24 hours from the symptoms onset (n¼7) were excluded from total study population.
Results: Of those, 26 (7.0%) patients had CTO lesions in a non-infarct related artery
(CTO patients). The LVEF estimated by echocardiography after primary PCI was similar
between CTO patients and patients without CTO lesion (non CTO patients) (53.58.6%
vs 57.79.4%; p¼0.06). CTO patients were signiﬁcantly more likely to be associated
with cardiogenic shock (23.1% vs 9.0%; p< 0.05) and to require intraaortic balloon
pumping (57.7% vs 13.1%; p< 0.001) and an extracorporeal membrane oxygenator
(7.7% vs 1.7%; p< 0.05) for hemodynamic support during PCI when compared withJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Conon CTO patients. Cardiogenic shock and 30-days mortality were signiﬁcantly higher in
CTO patients as compared with non CTO patients (23.1% vs 9.0%; p< 0.05, 7.7% vs
0.9%; p< 0.05, respectively). By multivariate analysis, 30-days survival as well as
cardiogenic shock were independently associated with CTO (odds ratio [OR] 9.44, 95%
CI 1.51-59.26, p¼0.04, OR 3.03, 95% CI 1.13-8.10, p¼0.03, respectively).
Conclusions: In patients with AMI, even if their LVEF were preserved, CTO was
strongly associated with cardiogenic shock and high mortality.
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Background: Chronic total occlusion (CTO) percutaneous coronary intervention
(PCI) has evolved signiﬁcantly with the development of the ’hybrid’ approach. We
sought to review the outcomes after CTO-PCI in a multi-centre registry of ’hybrid’
trained operators in the United Kingdom (UK).
Methods: The UK Hybrid CTO registry is a multicenter registry comprising
consecutive patients undergoing PCI for CTO in 7 UK centres (10 operators). Pro-
cedural and 30 day outcomes were deﬁned for 991 patients (1187 CTOs), representing
all procedures performed at these centres between January 2012 and April 2014. All
continuous variables are presented as mean  standard deviation, and categorical
variables as percentages.
Results: Mean age of the cohort was 64.410.2 years. 74% were male. 26% of pa-
tients had a prior PCI attempt and 22% had undergone previous surgical revascular-
ization. Lesion complexity was high (average J-CTO score of 2.5+-1.4, 71% had a
J-CTO score of 2 or higher). Average lesion length was 28 21mm. Initial procedural
strategy was antegrade wire escalation (AWE) in 62%, antegrade dissection re-entry
(ADR) in 12%, retrograde wiring (RW) in 12% and retrograde dissection re-entry
(RDR) in 14%. The average number of strategies utilized was 1.5  0.7. The ﬁnal
strategy was AWE (47%), ADR (22%), RW (8%) and RDR (23%). Technical success
rate per procedure (TIMI 3 ﬂow and < 30% stenosis) was 76%. Per patient success
rates (including repeat attempts) was 89%, highlighting the value of an ‘investment’
procedure. Mean wire crossing time was 4138 minutes. Procedural time was short
(mean 10846minutes) with 66% of cases completed in less than 2 hours. Contrast
(mean 305121ml) and radiation (mean ﬂuoroscopy time 4123minutes, mean dose-
area product 142059895cGycm2) exposure were relatively low. The in-hospital
major adverse cardiac event (MACE) rate was 1.1%. 30 day outcomes were favourable
with a MACE rate of 1.4%. The mortality rate was 0.2%, whilst unscheduled target
vessel revascularization rate was 0.5% (all stent thrombosis). Stroke occurred in 0.5%.
Conclusions: A hybrid approach to CTO-PCI is associated with high success rates
and low complications rates in the treatment of complex chronic total occlusion
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Background: We compared the in-hospital and the long-term clinical and angio-
graphic outcomes of the various intravascular ultrasound (IVUS) detected guidewire
(GW) induced coronary vessel injuries, following successful crossing of the CTO
segment between antegrade and retrograde approaches.
Methods: Two independent observers’ retrospectively analyzed all IVUS images of
173 CTO lesions (157 patients) successfully revascularized between August 2011 and
November 2012 in a high volume CTO center. IVUS detected GW induced coronary
vessel injuries were compared between the antegrade (113 lesions in 102 patients)
(Ante. group) and retrograde (60 lesions in 55 patients) (Retro. group) approaches, as
were the in-hospital and the long-term clinical and angiographic outcomes.
Results: IVUS showed that, in the Retro group, the GW more often tracked sub-
intimally, and induced dissections and coronary hematomas (p value for all was <
0.001)(Table), while the ﬁnal subintimal stenting was similar in both groups
(p¼0.47). Patients in the Retro group were likely to have an increased risk of peri-
procedural myocardial infarctions (p¼0.07), angiographic dissections (p< 0.001),
slow ﬂow (p¼0.02), and perforations (p¼0.02). There was no signiﬁcant difference
between the 2 groups regarding binary restenosis or target lesion revascularization
(p¼0.37, and p¼0.64, respectively). Five patients in the Retro group (9.4%) and one
in the Ante group (1%) died at one year (p¼0.02), mostly due to non-cardiac death.ronary Lesions - CTO B59
